You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.
To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Publication Date: February 16, 2022
Last Updated: November 29, 2023
Summary of Recommendations
Isocitrate dehydrogenase (IDH) mutational testing must be performed on all diffuse gliomas (DG). (S)
1226065
Overview
Title
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas